301126 达嘉维康
已收盘 11-15 15:00:00
资讯
新帖
简况
达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%
证券之星 · 11-04
达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%
达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 10-31
达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
证券之星 · 10-30
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
证券之星 · 10-10
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
达嘉维康(301126.SZ)：设立全资子公司再生医学研究院
智通财经 · 09-27
达嘉维康(301126.SZ)：设立全资子公司再生医学研究院
达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区
证券之星 · 09-10
达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区
商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。
美港电讯 · 09-09
商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。
A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。
美港电讯 · 09-05
A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。
达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司
证券之星 · 09-03
达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司
联邦制药与达嘉维康举行合作交流座谈会
联邦制药 · 09-03
联邦制药与达嘉维康举行合作交流座谈会
达嘉维康最新公告：股东拟减持不超过3%
证券之星 · 09-02
达嘉维康最新公告：股东拟减持不超过3%
达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份
智通财经 · 09-02
达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份
达嘉维康：股东拟减持不超过3%
美港电讯 · 09-02
达嘉维康：股东拟减持不超过3%
达嘉维康（301126）2024年中报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 08-31
达嘉维康（301126）2024年中报简析：营收净利润同比双双增长，三费占比上升明显
图解达嘉维康中报：第二季度单季净利润同比增327.62%
证券之星 · 08-29
图解达嘉维康中报：第二季度单季净利润同比增327.62%
达嘉维康(301126.SZ)发布上半年业绩，净利润3183.4万元，增长75.04%
智通财经 · 08-29
达嘉维康(301126.SZ)发布上半年业绩，净利润3183.4万元，增长75.04%
达嘉维康（301126）8月19日主力资金净卖出805.04万元
证券之星 · 08-20
达嘉维康（301126）8月19日主力资金净卖出805.04万元
达嘉维康：公司目前没有与猴痘相关业务。公司截止2024年8月9日股东人数为16576人
证券之星 · 08-19
达嘉维康：公司目前没有与猴痘相关业务。公司截止2024年8月9日股东人数为16576人
医药商业行业盘中拉升，达嘉维康涨5.26%
自选股智能写手 · 08-08
医药商业行业盘中拉升，达嘉维康涨5.26%
达嘉维康：回购公司股份按相关法律法规要求正常推进中，敬请关注公司后续披露的相关公告
证券之星 · 08-01
达嘉维康：回购公司股份按相关法律法规要求正常推进中，敬请关注公司后续披露的相关公告
公司概况
公司名称：
湖南达嘉维康医药产业股份有限公司
所属行业：
批发业
上市日期：
2021-12-07
主营业务：
湖南达嘉维康医药产业股份有限公司主要从事药品、生物制品、医疗器械等产品的分销及零售业务。公司主要服务包括分销业务、“特门服务”药房业务、DTP业务、生殖医院业务以及药房传统业务。公司凭借专业药房的规范化管理，2019年通过《零售药店经营特殊疾病药品服务规范》（“特药药房标准”），成为全国第一批达标药店，并荣获“2019年度十大DTP药房”、“2019年中国药品零售最具竞争力优秀门店”、“2019年度全国百家优秀民营医药商业流通企业”、“2020年优秀DTP专业药房”。
发行价格：
12.37
{"stockData":{"symbol":"301126","market":"SZ","secType":"STK","nameCN":"达嘉维康","latestPrice":11.45,"timestamp":1731654183000,"preClose":11.69,"halted":0,"volume":4683600,"delay":0,"floatShares":109000000,"shares":204999999,"eps":0.2285,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.24,"latestTime":"11-15 15:00:00","open":11.69,"high":11.93,"low":11.43,"amount":54924100,"amplitude":0.0428,"askPrice":11.45,"askSize":11,"bidPrice":11.44,"bidSize":49,"shortable":0,"etf":0,"ttmEps":0.2285,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":11.69,"symbolType":"stock","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":12.86,"lowLimit":10.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":205403200,"pbRate":1.36,"roa":"--","roe":"2.06%","epsLYR":0.17,"committee":0.0075,"marketValue":2352000000,"floatMarketCap":1244000000,"peRate":50.109411,"changeRate":-0.0205,"turnoverRate":0.0431,"status":1},"requestUrl":"/m/hq/s/301126/wiki","defaultTab":"wiki","newsList":[{"id":"2480713453","title":"达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480713453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480713453?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:07","pubTimestamp":1730711224,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年10月31日公司股东户数为1.56万户，较9月30日减少89.0户，减幅为0.57%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至10月31日，医药商业行业平均股东户数为3.96万户。从股价来看，2024年9月30日至2024年10月31日，达嘉维康区间涨幅为2.95%，在此期间股东户数减少89.0户，减幅为0.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400022563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2479798114","title":"达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2479798114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479798114?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:46","pubTimestamp":1730328362,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期达嘉维康发布2024年三季报。截至本报告期末，公司营业总收入39.83亿元，同比上升43.43%，归母净利润3645.04万元，同比上升53.04%。本报告期达嘉维康三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达39.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"gpt_icon":0},{"id":"2479278923","title":"达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479278923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479278923?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:29","pubTimestamp":1730280574,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年9月30日公司股东户数为1.57万户，较8月9日减少872.0户，减幅为5.26%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.96万户。从股价来看，2024年8月9日至2024年9月30日，达嘉维康区间涨幅为16.3%，在此期间股东户数减少872.0户，减幅为5.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000033813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2474979156","title":"达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474979156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474979156?lang=zh_cn&edition=full","pubTime":"2024-10-10 17:01","pubTimestamp":1728550896,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年9月30日公司股东户数为1.57万户，较8月9日减少872.0户，减幅为5.26%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.78万户。从股价来看，2024年8月9日至2024年9月30日，达嘉维康区间涨幅为16.3%，在此期间股东户数减少872.0户，减幅为5.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101000030146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2470775237","title":"达嘉维康(301126.SZ)：设立全资子公司再生医学研究院","url":"https://stock-news.laohu8.com/highlight/detail?id=2470775237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470775237?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:24","pubTimestamp":1727425458,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，公司以自有资金出资1000万元人民币设立全资子公司湖南达嘉维康再生医学研究院有限公司(“达嘉维康再生医学研究院”)。近日，达嘉维康再生医学研究院已完成工商注册登记，并取得了长沙县市场监督管理局下发的《营业执照》。据悉，本次设立全资子公司有利于进一步加强公司在医疗服务领域的发展力度，提升公司在该领域的基础研究和应用研究能力，实现公司在该领域的技术储备，相关研究成果转化。这一战略布局有望高效联动公司旗下子公司(长沙嘉辰生殖与遗传专科医院有限公司)的医疗服务板块，有助于公司更好地把握医疗健康产业的发展机遇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2466574435","title":"达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区","url":"https://stock-news.laohu8.com/highlight/detail?id=2466574435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466574435?lang=zh_cn&edition=full","pubTime":"2024-09-10 19:01","pubTimestamp":1725966090,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康(301126)09月10日在投资者关系平台上答复投资者关心的问题。投资者：达嘉维康海南分公司有位于这次药品进口免税区吗？达嘉维康董秘：您好，公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区。公司将持续关注市场需求和行业发展趋势，依据市场动态和公司战略规划，审慎考虑未来在药品进口免税区布局的可能性，以期更好地把握市场机遇，提升公司的市场竞争力和服务水平。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000030766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2466900911","title":"商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2466900911","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466900911?lang=zh_cn&edition=full","pubTime":"2024-09-09 10:24","pubTimestamp":1725848696,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0077","600838","BK0184","603883","BK0099","002336","BK0170","301126","600272","BK0188","600828","BK0209","BK0250","BK0189"],"gpt_icon":0},{"id":"2465956375","title":"A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2465956375","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465956375?lang=zh_cn&edition=full","pubTime":"2024-09-05 09:27","pubTimestamp":1725499657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0209","159938","BK1515","301017","603883","600829","159982","000705","BK1574","399300","BK0250","BK1161","09939","301126"],"gpt_icon":0},{"id":"2464809104","title":"达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2464809104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464809104?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:14","pubTimestamp":1725369279,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月3日达嘉维康发布公告称国金证券袁维 王奔奔、西部证券李梦园 邓琳茜、国盛证券张金洋 胡偌碧 张玉、海通证券余文心 周航 张澄 孙旭东、方正证券周超泽 窦慧敏 郭雪寒于2024年9月3日调研我司。截至2024年6月30日，公司在全国共计开设药房1,104家，其中直营门店989家，加盟门店115家，目前主要以直营连锁为主，门店已覆盖湖南、海南、宁夏、山西、北京、甘肃等地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300036988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600109","BK0250","BK0012","BK0201","002673","BK0188","BK0028","BK0183","BK0276","301126"],"gpt_icon":0},{"id":"2464882871","title":"联邦制药与达嘉维康举行合作交流座谈会","url":"https://stock-news.laohu8.com/highlight/detail?id=2464882871","media":"联邦制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464882871?lang=zh_cn&edition=full","pubTime":"2024-09-03 15:12","pubTimestamp":1725347568,"startTime":"0","endTime":"0","summary":"9月2日，联邦制药与达嘉维康在联邦制药珠海公司举行了合作交流座谈会。达嘉维康董事长王毅清一行受到联邦制药董事局主席蔡海山及高层管理团队的热情接待。座谈会上，蔡海山主席对王毅清董事 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20240903/c661389009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2464837648","title":"达嘉维康最新公告：股东拟减持不超过3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2464837648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464837648?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:39","pubTimestamp":1725284376,"startTime":"0","endTime":"0","summary":"达嘉维康公告，特定股东量吉投资及其一致行动人淳康投资计划减持公司股份数量合计不超过616.21万股（占公司总股本的3.00%）。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200033292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2464837815","title":"达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464837815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464837815?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:38","pubTimestamp":1725284303,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，公司收到股东量吉投资及其一致行动人淳康投资出具的《关于股份减持计划的告知函》，特定股东宁波梅山保税港区量吉股权投资合伙企业(有限合伙)(简称“量吉投资”)及其一致行动人宁波梅山保税港区淳康股权投资合伙企业(有限合伙)(简称“淳康投资”)计划自本公告披露之日起3个交易日后的3个月内以集中竞价或大宗交易方式减持公司股份数量合计不超过616.21万股(占公司总股本的3.00%)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2464832094","title":"达嘉维康：股东拟减持不超过3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2464832094","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464832094?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:38","pubTimestamp":1725284288,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2463271668","title":"达嘉维康（301126）2024年中报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2463271668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463271668?lang=zh_cn&edition=full","pubTime":"2024-08-31 06:38","pubTimestamp":1725057524,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期达嘉维康发布2024年中报。截至本报告期末，公司营业总收入26.0亿元，同比上升46.95%，归母净利润3183.4万元，同比上升75.04%。按单季度数据看，第二季度营业总收入13.2亿元，同比上升47.83%，第二季度归母净利润1239.71万元，同比上升327.62%。本报告期达嘉维康三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达43.66%。去年的净利率为0.97%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100009962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"gpt_icon":0},{"id":"2463284580","title":"图解达嘉维康中报：第二季度单季净利润同比增327.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463284580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463284580?lang=zh_cn&edition=full","pubTime":"2024-08-29 17:40","pubTimestamp":1724924457,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康2024年中报显示，公司主营收入26.0亿元，同比上升46.95%；归母净利润3183.4万元，同比上升75.04%；扣非净利润3111.06万元，同比上升90.32%；其中2024年第二季度，公司单季度主营收入13.2亿元，同比上升47.83%；单季度归母净利润1239.71万元，同比上升327.62%；单季度扣非净利润1172.94万元，同比上升631.76%；负债率69.84%，财务费用4836.48万元，毛利率19.19%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900034007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"gpt_icon":0},{"id":"2463407165","title":"达嘉维康(301126.SZ)发布上半年业绩，净利润3183.4万元，增长75.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463407165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463407165?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:09","pubTimestamp":1724918943,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)发布2024年半年度报告，该公司营业收入为26亿元，同比增长46.95%。归属于上市公司股东的净利润为3183.4万元，同比增长75.04%。归属于上市公司股东的扣除非经常性损益的净利润为3111.06万元，同比增长90.32%。基本每股收益为0.15元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126"],"gpt_icon":0},{"id":"2460409094","title":"达嘉维康（301126）8月19日主力资金净卖出805.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460409094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460409094?lang=zh_cn&edition=full","pubTime":"2024-08-20 09:20","pubTimestamp":1724116815,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月19日收盘，达嘉维康报收于9.49元，下跌3.36%，换手率5.29%，成交量5.8万手，成交额5560.77万元。近5日资金流向一览见下表：达嘉维康融资融券信息显示，融资方面，当日融资买入648.22万元，融资偿还563.47万元，融资净买入84.74万元。达嘉维康主营业务：主要从事药品、生物制品、医疗器械等产品的分销及零售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000007040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2460835082","title":"达嘉维康：公司目前没有与猴痘相关业务。公司截止2024年8月9日股东人数为16576人","url":"https://stock-news.laohu8.com/highlight/detail?id=2460835082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460835082?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:02","pubTimestamp":1724065337,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康08月19日在投资者关系平台上答复投资者关心的问题。公司截止2024年8月9日股东人数为16576人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900025789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2457389632","title":"医药商业行业盘中拉升，达嘉维康涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457389632","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457389632?lang=zh_cn&edition=full","pubTime":"2024-08-08 09:35","pubTimestamp":1723080945,"startTime":"0","endTime":"0","summary":"08月08日，医药商业行业盘中拉升，截至09点35分，医药商业行业整体指数上涨0.95%，报4620.230点。从个股上来看，该行业的成分股中，达嘉维康涨5.26%，华人健康、开开实业、塞力医疗涨幅居前。从资金上来看，截止发稿，医药商业行业主力净流入为-1409.28万，其中开开实业受到资金热捧，主力净流入573.84万；拉长时间线来看，该板块近20日主力资金净流入-2141.52万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808093545af967ed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808093545af967ed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0209","159938","BK0184","BK0099","BK0250","600272","301126"],"gpt_icon":0},{"id":"2456517001","title":"达嘉维康：回购公司股份按相关法律法规要求正常推进中，敬请关注公司后续披露的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2456517001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456517001?lang=zh_cn&edition=full","pubTime":"2024-08-01 17:06","pubTimestamp":1722503170,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康08月01日在投资者关系平台上答复投资者关心的问题。对于参股分红情况，请您关注定期报告中披露的投资收益数据。公司青霉素车间建设加速推进中，预计今年可投入使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080100034154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-12-07","address":"湖南省长沙市岳麓区茯苓路30号","stockEarnings":[{"period":"1week","weight":-0.0584},{"period":"1month","weight":0.0651},{"period":"3month","weight":0.166},{"period":"6month","weight":0.1394},{"period":"1year","weight":-0.1614},{"period":"ytd","weight":-0.1177}],"companyName":"湖南达嘉维康医药产业股份有限公司","boardCode":"AI0051","perCapita":"6956股","boardName":"批发业","registeredCapital":"20540万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":" 湖南达嘉维康医药产业股份有限公司主要从事药品、生物制品、医疗器械等产品的分销及零售业务。公司主要服务包括分销业务、“特门服务”药房业务、DTP业务、生殖医院业务以及药房传统业务。公司凭借专业药房的规范化管理，2019年通过《零售药店经营特殊疾病药品服务规范》（“特药药房标准”），成为全国第一批达标药店，并荣获“2019年度十大DTP药房”、“2019年中国药品零售最具竞争力优秀门店”、“2019年度全国百家优秀民营医药商业流通企业”、“2020年优秀DTP专业药房”。","serverTime":1731849578008,"listedPrice":12.37,"stockholders":"15615人(较上一季度减少0.57%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达嘉维康,301126,达嘉维康股票,达嘉维康股票老虎,达嘉维康股票老虎国际,达嘉维康行情,达嘉维康股票行情,达嘉维康股价,达嘉维康股市,达嘉维康股票价格,达嘉维康股票交易,达嘉维康股票购买,达嘉维康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}